Cart
sales@molnova.com
Home -
Products -
Others -
Other Targets -
Piperazine, 1-(4-fluorophenyl)-4-[(3,4,5-trimethoxyphenyl)methyl]-
Piperazine, 1-(4-fluorophenyl)-4-[(3,4,5-trimethoxyphenyl)methyl]-
CAS No. 80305-11-9
Piperazine, 1-(4-fluorophenyl)-4-[(3,4,5-trimethoxyphenyl)methyl]-( —— )
Catalog No. M28945 CAS No. 80305-11-9
Piperazine, 1-(4-fluorophenyl)-4-[(3,4,5-trimethoxyphenyl)methyl]- is a piperazine derivative.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 49 | In Stock |
|
| 2MG | 29 | In Stock |
|
| 5MG | 45 | In Stock |
|
| 10MG | 64 | In Stock |
|
| 25MG | 104 | In Stock |
|
| 50MG | 151 | In Stock |
|
| 100MG | 223 | In Stock |
|
| 200MG | 318 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePiperazine, 1-(4-fluorophenyl)-4-[(3,4,5-trimethoxyphenyl)methyl]-
-
NoteResearch use only, not for human use.
-
Brief DescriptionPiperazine, 1-(4-fluorophenyl)-4-[(3,4,5-trimethoxyphenyl)methyl]- is a piperazine derivative.
-
DescriptionPiperazine, 1-(4-fluorophenyl)-4-[(3,4,5-trimethoxyphenyl)methyl]- is a piperazine derivative.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorPHGDH
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number80305-11-9
-
Formula Weight360.42
-
Molecular FormulaC20H25FN2O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOC1=CC(CN2CCN(CC2)C2=CC=C(F)C=C2)=CC(OC)=C1OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Acetylsulfamerazine
Acetylsulfamerazine (N-Acetylsulfamerazine) is a secondary metabolite of sulphamethazine, which has a slight inhibitory effect on cellulose digestion and rumen endocrine activity, and has anti-microbial activity.
-
PUMA BH3
PUMA BH3 is a p53 upregulated modulator of apoptosis (PUMA) BH3 domain peptide, acts as a direct activator of Bak, with a Kd of 26 nM.This is a PUMA BH3 domain peptide. PUMA proteins bind Bcl-2, localize to the mitochondria, and induce cytochrome C release and apoptosis in response to p53. PUMA may be a direct mediator of p53-induced apoptosis.
-
Ladiratuzumab
LadiratuzumAb (hLIV22) is a humanized monoclonal antibody targeting LIV-1/ZIP6.LadiratuzumAb is a naked antibody to SGN-LIV1A and is capable of synthesizing an antibody-activated molecule coupling (ADC), SGN-LIV1A.
